China Natural Resources Receives Nasdaq Notification Regarding Minimum Bid Requirements
HONG KONG, May 3, 2022 /PRNewswire/ -- On April 27, 2022, China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Capital Market ("Nasdaq") notifying the Company that it is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2), because the closing...
Biomerics Announces Image Guided Intervention (IGI) Division
SALT LAKE CITY, May 2, 2022 /PRNewswire/ -- Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics' IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally...
WATERDROP ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR
BEIJING, May 2, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced the appointment of Mr. Ning Zhu as a new independent director to its board of directors (the "Board") and the resignation of Mr. Peng Shen as a...
CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022
CORALVILLE, Iowa, May 2, 2022 /PRNewswire/ -- CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will unveil the TotalRT All in One Solution along with several innovative solutions during the annual ESTRO Congress in Copenhagen, Denmark, 6-10 May 2022. A special product showcase will take place 6 May at 18:35. The TotalRT Platform is designed to quickly adapt CIVCO RT's positioning...
ASCENSIA DIABETES CARE PRESENTS NEW RESEARCH SHOWING THAT PEOPLE USING THE CONTOUR® BLOOD GLUCOSE MONITORING SYSTEM AND APP EXPERIENCE FEWER OUT-OF-TARGET BLOOD GLUCOSE LEVELS
BASEL, Switzerland, May 2, 2022 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR® blood glucose monitoring (BGM) system portfolio and distributor of the Eversense® continuous glucose monitoring (CGM) system, announces a new study demonstrating that people who use the connected CONTOUR® BGM systems (BGMS) and CONTOUR®DIABETES App...
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Frozen embryos, sperm and eggs will be big travellers in post COVID-19 cross border reproductive care
SINGAPORE, May 2, 2022 /PRNewswire/ -- The aftermath of the COVID-19 pandemic is expected to have major impacts on the nature of cross border reproductive care where infertile couples and individuals in the past travelled extensively abroad to access medically assisted conception. The 2022 Congress of the Asia Pacific Initiative on Reproduction...
Servatus strengthens Board with appointment of biopharmaceutical division head at Boehringer Ingelheim, Dr Uwe Buecheler
New Board appointment deepens and consolidates Servatus' extensive commercial and scientific expertise for its global biotherapeutics programs Dr Buecheler joins as Non-Executive Director from leading pharmaceutical giant Boehringer Ingelheim in Germany, where he is both Senior Vice President and Senior Advisor Biopharmaceuticals to the Board of Directors +30 years at Boehringer Ingelheim, he leads the biopharmaceuticals...
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Recognising the ‘tip of the iceberg’ in the complex and chronic effects of endometriosis
SINGAPORE, May 1, 2022 /PRNewswire/ -- Leaders in reproductive medicine from more than 100 countries were today urged to help prevent women suffering from the debilitating effects of endometriosis from embarking on "diagnostic misadventures." Speaking at the 2022 Congress of the Asia Pacific Initiative on Reproduction (ASPIRE), Professor Hugh Taylor, an eminent...
Asia Pacific Initiative on Reproduction (ASPIRE) 2022 Congress: Linking male infertility diagnosis with the window to future health trajectories
SINGAPORE, May 1, 2022 /PRNewswire/ -- Male infertility factors are emerging as likely biomarkers for later life health events including hospital treatments and possible premature death from conditions such as cancer, cardiovascular and metabolic diseases. Lifestyle and social factors, including partner and child relationships, may also be intertwined in the fertility status...
Inmagene Receives FDA’s IND Clearance for OX40 Antagonist
SAN DIEGO and SHANGHAI and SYDNEY, April 30, 2022 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") announces that the U.S. Food and Drug Administration (FDA) has cleared drug candidate IMG-007, a monoclonal antibody against OX40, to proceed to Phase I clinical development. Inmagene is developing IMG-007 in partnership with HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13). IMG-007 is highly potent at blocking...
